EVT
EVOTEC SE INH O.N.
Stock XETRA – Stock Market Prices, News & Analysis
Evotec SE is a biotechnology company focused on drug discovery and the development of therapies for rare and complex diseases.
EVOTEC SE INH O.N.
EVT
Evotec SE is a biotechnology company focused on drug discovery and the development of therapies for rare and complex diseases.
Price history of EVOTEC SE INH O.N.
Price history of EVOTEC SE INH O.N.
Performance & Momentum
Strategic Analysis
EVOTEC SE INH O.N. • 2026
Evotec SE is a German biotechnology company specializing in the discovery and development of drugs for rare and complex diseases, operating through innovative partnerships with pharmaceutical players. Its model relies on cutting-edge technological expertise and vertical integration that strengthen its position in the medical R&D value chain.
Strengths
- Strong focus on high-potential therapeutic niches in rare and complex diseases
- Strategic partnerships with global pharmaceutical leaders
- Advanced technological expertise in discovery and development processes
Weaknesses
- Sustained poor stock performance reflecting operational or market challenges
- Sensitivity to long cycles and uncertainties inherent to biotechnology
Momentum
The extremely weak momentum reflects ongoing pressure on the stock, compounded by sustained negative performance over several years. This situation calls for heightened vigilance; recovery will heavily depend on clinical advances and the renewal of partnerships.
Similar stocks to EVOTEC SE INH O.N.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
